Diversey, Inc., a global leader in healthcare and infection prevention products and solutions, today announced it will test several of its disinfectant products for efficacy against SARS-CoV-2, which causes COVID-19. These results will be submitted to the EPA for approval.
“With a mission to protect and care for people every day, infection prevention is a major focus for Diversey,” said Mark Copeland, CMO for Diversey, Inc. “Up until now, healthcare providers and others have been looking at the EPA's Emerging Viral Pathogens Program for guidance, and more recently for claims against human coronavirus, on what products may work as disinfectants based on knowledge of similar pathogens. The Emerging Viral Pathogens Program is intended to bridge the gap between when outbreaks occur and novel viruses are available to test for specific product efficacy.”
Diversey has partnered with Microbac Laboratories, Inc. to test several of its products for effectiveness against SARS-CoV-2. Microbac is a leading testing laboratory that offers antiviral and antimicrobial efficacy testing for various disinfectants, sanitizers, antiseptics, and devices, against SARS, MERS, and other microorganisms. Microbac is one of the only testing laboratories in the world certified by the CDC to test the effectiveness of products against SARS-CoV-2 and viruses like it.
“Protecting the public against SARS-CoV-2 is an all-hands-on-deck issue," said Trevor Boyce, Microbac's Chairman and CEO. "We are eager to apply our scientific knowledge and experience to our work with a global leader like Diversey, to develop new tools in the fight against this pandemic."
“Creating a safer environment for all people, including patients, providers, and the public, is critical in this time, and Diversey is committed to continue to provide products and practices to optimize outcomes,” added Copeland.
This test data will not replace the EPA List N and guidelines for disinfectants for use against SARS-CoV-2 at this time. All products on this list meet EPA’s criteria for use against SARS-CoV-2, the virus that causes COVID-19. The testing will provide added assurance for specific efficacy against this virus. Until there is further EPA guidance, disinfectants found on the EPA's List N should continue to be used according to their label instructions.
The following Diversey products can be found on List N: https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2
Diversey’s purpose is to protect and care for people every day. Diversey has been, and always will be, a pioneer and facilitator for life. We constantly deliver revolutionary cleaning and hygiene technologies that provide total confidence to our customers across all of our global sectors, including: cleaning products, systems and services that efficiently integrate chemicals, machines and sustainability programs. This makes us unique among leading global hygiene and cleaning companies. Everything we do has our customers’ needs at its heart and is based on the belief that cleaning and hygiene are life essentials. With over 95 years of expertise, we safeguard our customers’ businesses, contributing to productivity improvements, lower total operating costs and brand protection.
Diversey is headquartered in Fort Mill, SC, USA. For more information, visit www.diversey.com or follow us on social media.
About Microbac Laboratories
Microbac Laboratories operates the largest network of privately held testing facilities in the United States, providing broad analytical offerings and testing insights across the environmental, food and life science markets. A family-run company with more than 50 years' experience honing its craft, Microbac is on a mission to improve the world around us, one test at a time.
PR Contact for this story:
Larinda Becker - Healthcare Marketing Director, Diversey, Inc.